ARCHIVES

Telatinib Demonstrates Positive Results in First-Line Treatment

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Approves New Device For Glioblastoma Multiforme

April 29, 2011

High Risk workshop Planned To Produce Monograph On Current Knowledge

October 11, 1974

Panel Recommends 5-FU/Levamisole For Adjuvant Stage 3 Colon Cancer

April 27, 1990

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992

FY09 Proposal for NIH Flat. NCI “Bypass Budget” Makes Case for $6 Billion.

February 8, 2008

IOM Report Links Agent Orange, CLL

January 24, 2003